´ëÇѰǼ±ÇÐȸ Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö : 2023-12-02 |
|
´ëÇѰǼ±ÇÐȸ Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö : 2023-12-02 ±³À°ÁÖÁ¦ : "Á¦11ȸ °Ç¼± »ý¹°ÇÐÁ¦Á¦ ½ÉÆ÷Áö¾ö" ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : ÃÖÀ¯¼º ±³¼ö(±âȹÁ¤Ã¥ÀÌ»ç) À̸ÞÀÏ : cardura@naver.com ±³À°Á¾·ù : ÇǺΰú Âü¼®¿¹»óÀÎ : 70¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 0¿ø ºñ°í
±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 13:00~13:30 Basic science of neutrophils in psoriasis È«Àå¿ø(°æºÏÀÇ´ë »ý¸®Çб³½Ç) ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 13:30~14:00 Mastering strategies to managing palmoplantar pustulosis Á¶¼ºÁø(¼¿ïÀÇ´ë) ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 14:00~14:30 Generalized pustular psoriasis as a rare and extreme form ±èűÕ(¿¬¼¼ÀÇ´ë) Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 14:30~14:40 Q&A È«Àå¿ø, Á¶¼ºÁø, ±èűÕ(°æºÏÀÇ´ë, ¼¿ïÀÇ´ë, ¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 14:40~15:10 Role of TYK2 Pathway in Psoriasis À̽ÂÈ¿(KAIST) ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 15:10~15:40 Clinical data from TYK2 inhibitor in treatment of Posirasis ¹æöȯ(Ä«Å縯ÀÇ´ë) Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 15:40~15:50 Q&A À̽ÂÈ¿, ¹æöȯ(KAIST, Ä«Å縯ÀÇ´ë) ÈÞ½Ä 12¿ù 02ÀÏ ¶óº¥´õȦ 15:50~16:10 ÈÞ½Ä () ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 16:10~16:40 Patients with psoriasis resistant to multiple biological therapies Á¤±âÇå(°æÈñÀÇ´ë) ±³À°½Ã°£ 12¿ù 02ÀÏ ¶óº¥´õȦ 16:40~17:10 Biologic tapering for patients with psoriasis with low disease activity ±èµ¿Çö(Â÷ÀÇ´ë) Åä·Ð 12¿ù 02ÀÏ ¶óº¥´õȦ 17:10~17:20 Q&A Á¤±âÇå, ±èµ¿Çö(°æÈñÀÇ´ë, Â÷ÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|